Back to 
Bank of New York Mellon Corp
Bank of New York Mellon Corp
SNDXShowing 8 of 23 quarters
Position history for Bank of New York Mellon Corp's holdings in SYNDAX PHARMACEUTICALS INC
Bank of New York Mellon Corp holds 1M shares of SNDX (SYNDAX PHARMACEUTICALS INC), worth $22.7M as of 2026-Q2. The position was increased (+3.5% shares). SNDX represents 0.0% of Bank of New York Mellon Corp's portfolio.
Current Value
$22.7M
Current Shares
1M
Total Value Change
+$18.5M
Total Shares Change
+818,577
Quarter-by-Quarter History
Other major holders of SNDX: WELLINGTON MANAGEMENT GROUP LLP, BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.